Fundraising FoxTandem Tx
1 known investors
Find your way into Tandem Tx
Sign up to see every warm intro you have to Tandem Tx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tandem Tx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TANDEM Therapeutics is an early-stage biopharmaceutical company developing precision therapies for fibrosis and fibrotic cancers using Matrix Targeting Peptides that address disease-associated extracellular matrix alterations. Its pipeline of conditionally targeted therapies is based on research from ETH Zürich and the Paul Scherrer Institute in matrix mechanobiology.
Founders & leadership
MC
Mamta ChabriaCofounder
VV
Viola VogelCofounder
MB
Martin BeheCofounder
Investors · 1
Kickfundlisted by KickfundBasel · $950K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Tandem Tx do?
- TANDEM Therapeutics is an early-stage biopharmaceutical company developing precision therapies for fibrosis and fibrotic cancers using Matrix Targeting Peptides that address disease-associated extracellular matrix alterations. Its pipeline of conditionally targeted therapies is based on research from ETH Zürich and the Paul Scherrer Institute in matrix mechanobiology.
- Who founded Tandem Tx?
- Tandem Tx was founded by Mamta Chabria, Viola Vogel, Martin Behe.
- Who are Tandem Tx's investors?
- Tandem Tx's investors include Kickfund.